GLP-1 receptor agonists have a role in improving glycemic control, and reducing the risk of major adverse cardiovascular events in people with type 2 diabetes.

Targeting CV Outcomes with GLP-1 Receptor Agonists

GetBriefed Podcast is the latest mdBriefCase Group offering, developed to inform healthcare practitioners regarding a variety of relevant medical topics, and available on a convenient downloadable platform. Now, access education from leading medical experts on-the-go!

mdBriefCase Group is Canada’s foremost, online continuing medical education (CME) provider, with a membership of over 110,000 Canadian healthcare practitioners who currently use and help shape content. We provide FREE multimedia, interactive and accredited learning programs written by leading medical specialists and developed by prestigious educational institutions.

Education

GetBriefed Podcast is the latest mdBriefCase Group offering, developed to inform healthcare practitioners regarding a variety of relevant medical topics, and available on a convenient downloadable platform. Now, access education from leading medical experts on-the-go! mdBriefCase Group is Canada’s foremost, online continuing medical education (CME) provider, with a membership of over 110,000 Canadian healthcare practitioners who currently use and help shape content. We provide FREE multimedia, interactive and accredited learning programs written by leading medical specialists and developed by prestigious educational institutions.

Share Targeting CV Outcomes with GLP-1 Receptor Agonists

Sign up to save your podcasts

Targeting CV Outcomes with GLP-1 Receptor Agonists

Targeting CV Outcomes with GLP-1 Receptor Agonists